• 1
    Hollingsworth MA,Swanson BJ. Mucins in cancer: protection and control of the cell surface. Nat Rev Cancer 2004; 4: 4560.
  • 2
    Gendler SJ,Lancaster CA,Taylor-Papadimitriou J,Duhig T,Peat N,Burchell J,Pemberton L,Lalani EN,Wilson D. Molecular cloning and expression of human tumor-associated polymorphic epithelial mucin. J Biol Chem 1990; 265: 1528693.
  • 3
    Berg EL,Robinson MK,Mansson O,Butcher EC,Magnani JL. A carbohydrate domain common to both sialyl Le (a) and sialyl Le (x) is recognized by the endothelial cell leukocyte adhesion molecule ELAM-1. J Biol Chem 1991; 266: 1486972.
  • 4
    Varki A. Selectin ligands. Proc Natl Acad Sci USA 1994; 91: 73907.
  • 5
    Kim YJ,Borsig L,Han HL,Varki NM,Varki A. Distinct selectin ligands on colon carcinoma mucins can mediate pathological interactions among platelets, leukocytes, and endothelium. Am J Pathol 1999; 155: 46172.
  • 6
    Borsig L,Wong R,Feramisco J,Nadeau DR,Varki NM,Varki A. Heparin and cancer revisited: mechanistic connections involving platelets, P-selectin, carcinoma mucins, and tumor metastasis. Proc Natl Acad Sci USA 2001; 98: 33527.
  • 7
    McEver RP. Selectins: lectins that initiate cell adhesion under flow. Curr Opin Cell Biol 2002; 14: 5816.
  • 8
    Takada A,Ohmori K,Yoneda T,Tsuyuoka K,Hasegawa A,Kiso M,Kannagi R. Contribution of carbohydrate antigens sialyl Lewis A and sialyl Lewis X to adhesion of human cancer cells to vascular endothelium. Cancer Res 1993; 53: 35461.
  • 9
    Kodera Y,Yamamura Y,Torii A,Uesaka K,Hirai T,Yasui K,Morimoto T,Kato T,Kito T. The prognostic value of preoperative serum levels of CEA and CA19-9 in patients with gastric cancer. Am J Gastroenterol 1996; 91: 4953.
  • 10
    Nakayama T,Watanabe M,Katsumata T,Teramoto T,Kitajima M. Expression of sialyl Lewis(a) as a new prognostic factor for patients with advanced colorectal carcinoma. Cancer 1995; 75: 20516.
  • 11
    Dabelsteen E. Cell surface carbohydrates as prognostic markers in human carcinomas. J Pathol 1996; 179: 35869.
  • 12
    Ho SB,Niehans GA,Lyftogt C,Yan PS,Cherwitz DL,Gum ET,Dahiya R,Kim YS. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res 1993; 53: 64151.
  • 13
    Taylor-Papadimitriou J,Burchell JM,Plunkett T,Graham R,Correa I,Miles D,Smith M. MUC1 and the immunobiology of cancer. J Mammary Gland Biol Neoplasia 2002; 7: 58894.
  • 14
    Kohno N,Akiyama M,Kyoizumi S,Hakoda M,Kobuke K,Yamakido M. Detection of soluble tumor-associated antigens in sera and effusions using novel monoclonal antibodies, KL-3 and KL-6, against lung adenocarcinoma. Jpn J Clin Oncol 1988; 18: 20316.
  • 15
    Stahel RA,Gilks WR,Lehmann HP,Schenker T. Third international workshop on lung tumor and differentiation antigens: overview of the results of the central data analysis. Int J Cancer 1994; 59 (Suppl 8): 626.
  • 16
    Hirasawa Y,Kohno N,Yokoyama A,Inoue Y,Abe M,Hiwada K. KL-6, a human MUC1 mucin, is chemotactic for human fibroblasts. Am J Respir Cell Mol Biol 1997; 17: 5017.
  • 17
    Kohno N,Inoue Y,Hamada H,Fujioka S,Fujino S,Yokoyama A,Hiwada K,Ueda N,Akiyama M. Difference in sero-diagnostic values among KL-6-associated mucins classified as cluster 9. Int J Cancer 1994; 59 (Suppl 8): 813.
  • 18
    Kohno N,Kyoizumi S,Tanabe M,Oyama T,Vossler M,Yamakido M,Akiyama M. Detection of a circulating tumor-associated antigen with a murine monoclonal antibody, LISA 101, selected by reversed indirect enzyme-linked immunosorbent assay. Cancer Res 1989; 49: 341219.
  • 19
    Hamada H,Kohno N,Hiwada K. A new serum tumor marker, CAM 123-6, highly specific to pulmonary adenocarcinoma. Jpn J Cancer Res 1994; 85: 21119.
  • 20
    Baeckstrom D,Karlsson N,Hansson GC. Purification and characterization of sialyl-Le(a)-carrying mucins of human bile; evidence for the presence of MUC1 and MUC3 apoproteins. J Biol Chem 1994; 269: 144307.
  • 21
    Fernandez-Rodriguez J,Dwir O,Alon R,Hansson GC. Tumor cell MUC1 and CD43 are glycosylated differently with sialyl-Lewis a and x epitopes and show variable interactions with E-selectin under physiological flow conditions. Glycoconj J 2001; 18: 92530.
  • 22
    Burdick MD,Harris A,Reid CJ,Iwamura T,Hollingsworth MA. Oligosaccharides expressed on MUC1 produced by pancreatic and colon tumor cell lines. J Biol Chem 1997; 272: 24198202.
  • 23
    Baruch A,Hartmann M,Yoeli M,Adereth Y,Greenstein S,Stadler Y,Skornik Y,Zaretsky J,Smorodinsky NI,Keydar I,Wreschner DH. The breast cancer-associated MUC1 gene generates both a receptor and its cognate binding protein. Cancer Res 1999; 59: 155261.
  • 24
    Brayman M,Thathiah A,Carson DD. MUC1: a multifunctional cell surface component of reproductive tissue epithelia. Reprod Biol Endocrinol 2004; 2: 4.
  • 25
    Ogawa Y,Ishikawa T,Ikeda K,Nakata B,Sawada T,Ogisawa K,Kato Y,Hirakawa K. Evaluation of serum KL-6, a mucin-like glycoprotein, as a tumor marker for breast cancer. Clin Cancer Res 2000; 6: 406972.
  • 26
    Kishimoto T,Ishikura H,Kimura C,Takahashi T,Kato H,Yoshiki T. Phenotypes correlating to metastatic properties of pancreas adenocarcinoma in vivo: the importance of surface sialyl Lewis(a) antigen. Int J Cancer 1996; 69: 2904.
  • 27
    Yamada N,Chung YS,Takatsuka S,Arimoto Y,Sawada T,Dohi T,Sowa M. Increased sialyl Lewis A expression and fucosyltransferase activity with acquisition of a high metastatic capacity in a colon cancer cell line. Br J Cancer 1997; 76: 5827.
  • 28
    McDermott KM,Crocker PR,Harris A,Burdick MD,Hinoda Y,Hayashi T,Imai K,Hollingsworth MA. Overexpression of MUC1 reconfigures the binding properties of tumor cells. Int J Cancer 2001; 94: 78391.
  • 29
    Kam JL,Regimbald LH,Hilgers JH,Hoffman P,Krantz MJ,Longenecker BM,Hugh JC. MUC1 synthetic peptide inhibition of intercellular adhesion molecule-1 and MUC1 binding requires six tandem repeats. Cancer Res 1998; 58: 557781.
  • 30
    Brinkman-Van der Linden EC,Varki A. New aspects of siglec binding specificities, including the significance of fucosylation and of the sialyl-Tn epitope. Sialic acid-binding immunoglobulin superfamily lectins. J Biol Chem 2000; 275: 862532.
  • 31
    Kondo K,Kohno N,Yokoyama A,Hiwada K. Decreased MUC1 expression induces E-cadherin-mediated cell adhesion of breast cancer cell lines. Cancer Res 1998; 58: 201419.
  • 32
    Wesseling J,van der Valk SW,Vos HL,Sonnenberg A,Hilkens J. Episialin (MUC1) overexpression inhibits integrin-mediated cell adhesion to extracellular matrix components. J Cell Biol 1995; 129: 25565.